PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"33378609","Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group.","N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.","Baden LR","N Engl J Med","2021","2020/12/30","PMC7787219","","10.1056/NEJMoa2035389"
"25102681","Back to the bench","Corey L.","IAVI Rep. 2014;18(2):15-7.","Corey L","IAVI Rep","2014","2014/08/09","","",""
"26933962","Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?","Gray GE, Laher F, Doherty T, Abdool Karim S, Hammer S, Mascola J, Beyrer C, Corey L.","PLoS Biol. 2016 Mar 2;14(3):e1002372. doi: 10.1371/journal.pbio.1002372. eCollection 2016 Mar.","Gray GE","PLoS Biol","2016","2016/03/03","PMC4774984","","10.1371/journal.pbio.1002372"
"29889809","Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants","Boucoiran I, Mayer BT, Krantz EM, Marchant A, Pati S, Boppana S, Wald A, Corey L, Casper C, Schiffer JT, Gantt S.","Pediatr Infect Dis J. 2018 Jul;37(7):627-631. doi: 10.1097/INF.0000000000001877.","Boucoiran I","Pediatr Infect Dis J","2018","2018/06/12","PMC6016842","NIHMS929920","10.1097/INF.0000000000001877"
"28368743","Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults","Huang Y, Zhang L, Ledgerwood J, Grunenberg N, Bailer R, Isaacs A, Seaton K, Mayer KH, Capparelli E, Corey L, Gilbert PB.","MAbs. 2017 Jul;9(5):792-800. doi: 10.1080/19420862.2017.1311435. Epub 2017 Apr 3.","Huang Y","MAbs","2017","2017/04/04","PMC5524155","","10.1080/19420862.2017.1311435"
"25820067","Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials","Jin X, Morgan C, Yu X, DeRosa S, Tomaras GD, Montefiori DC, Kublin J, Corey L, Keefer MC; NIAID HIV Vaccine Trials Network.","Vaccine. 2015 May 11;33(20):2347-53. doi: 10.1016/j.vaccine.2015.03.036. Epub 2015 Mar 25.","Jin X","Vaccine","2015","2015/03/31","PMC4433533","NIHMS674130","10.1016/j.vaccine.2015.03.036"
"26865856","Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons","Bender Ignacio RA, Goldman JD, Magaret AS, Selke S, Huang ML, Gantt S, Johnston C, Phipps WT, Schiffer JT, Zuckerman RA, McClelland RS, Celum C, Corey L, Wald A, Casper C.","Infect Agent Cancer. 2016 Feb 10;11:7. doi: 10.1186/s13027-016-0052-2. eCollection 2016.","Bender Ignacio RA","Infect Agent Cancer","2016","2016/02/12","PMC4748452","","10.1186/s13027-016-0052-2"
"18698002","Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation","Woolfrey AE, Malhotra U, Harrington RD, McNevin J, Manley TJ, Riddell SR, Coombs RW, Appelbaum FR, Corey L, Storb R.","Blood. 2008 Oct 15;112(8):3484-7. doi: 10.1182/blood-2008-05-157511. Epub 2008 Aug 12.","Woolfrey AE","Blood","2008","2008/08/14","PMC2569185","","10.1182/blood-2008-05-157511"
"30020484","Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals","Agyemang E, Magaret AS, Selke S, Johnston C, Corey L, Wald A.","J Infect Dis. 2018 Oct 20;218(11):1691-1699. doi: 10.1093/infdis/jiy372.","Agyemang E","J Infect Dis","2018","2018/07/19","PMC6195656","","10.1093/infdis/jiy372"
"17329447","Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa","Magaret AS, Wald A, Huang ML, Selke S, Corey L.","J Clin Microbiol. 2007 May;45(5):1618-20. doi: 10.1128/JCM.01405-06. Epub 2007 Feb 28.","Magaret AS","J Clin Microbiol","2007","2007/03/03","PMC1865863","","10.1128/JCM.01405-06"
"15243920","Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women","Taylor MM, Chohan B, Lavreys L, Hassan W, Huang ML, Corey L, Ashley Morrow R, Richardson BA, Mandaliya K, Ndinya-Achola J, Bwayo J, Kreiss J.","J Infect Dis. 2004 Aug 1;190(3):484-8. doi: 10.1086/421466. Epub 2004 Jul 7.","Taylor MM","J Infect Dis","2004","2004/07/10","PMC6768555","NIHMS1052012","10.1086/421466"
"15478066","Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics","Blower S, Wald A, Gershengorn H, Wang F, Corey L.","J Infect Dis. 2004 Nov 1;190(9):1610-7. doi: 10.1086/424850. Epub 2004 Sep 30.","Blower S","J Infect Dis","2004","2004/10/13","","","10.1086/424850"
"23614998","Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants","Fuchs JD, Sobieszczyk ME, Madenwald T, Grove D, Karuna ST, Andrasik M, Sherwat A, Broder G, Mayer K, Koblin B, Hammer S; HVTN 505 Protocol Team.","J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):259-62. doi: 10.1097/QAI.0b013e318296df94.","Fuchs JD","J Acquir Immune Defic Syndr","2013","2013/04/26","PMC3714219","NIHMS480350","10.1097/QAI.0b013e318296df94"
"21239996","Systemic and mucosal differences in HIV burden, immune, and therapeutic responses","Wahl SM, Redford M, Christensen S, Mack W, Cohn J, Janoff EN, Mestecky J, Jenson HB, Navazesh M, Cohen M, Reichelderfer P, Kovacs A; DATRI 009 Study Group.","J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):401-11. doi: 10.1097/QAI.0b013e31820cdfdb.","Wahl SM","J Acquir Immune Defic Syndr","2011","2011/01/18","PMC3164950","NIHMS267199","10.1097/QAI.0b013e31820cdfdb"
"23370155","Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?","Gray GE, Metch B, Churchyard G, Mlisana K, Nchabeleng M, Allen M, Moodie Z, Kublin J, Bekker LG; HVTN 503 team.","Vaccine. 2013 Apr 12;31(16):2089-96. doi: 10.1016/j.vaccine.2013.01.031. Epub 2013 Jan 29.","Gray GE","Vaccine","2013","2013/02/02","PMC3942784","NIHMS487911","10.1016/j.vaccine.2013.01.031"
"24560541","Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study","Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.","Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.","Gray GE","Lancet Infect Dis","2014","2014/02/25","PMC4174314","NIHMS588579","10.1016/S1473-3099(14)70020-9"
"20706632","Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity","Graham BS, McElrath MJ, Keefer MC, Rybczyk K, Berger D, Weinhold KJ, Ottinger J, Ferarri G, Montefiori DC, Stablein D, Smith C, Ginsberg R, Eldridge J, Duerr A, Fast P, Haynes BF; AIDS Vaccine Evaluation Group.","PLoS One. 2010 Aug 10;5(8):e11995. doi: 10.1371/journal.pone.0011995.","Graham BS","PLoS One","2010","2010/08/14","PMC2919382","","10.1371/journal.pone.0011995"
"21570355","Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.","Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11.","Gray GE","Lancet Infect Dis","2011","2011/05/17","PMC3417349","NIHMS357717","10.1016/S1473-3099(11)70098-6"
"21742841","IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection","Scott J, Holte S, Urban T, Burgess C, Coppel E, Wang C, Corey L, McHutchison J, Goldstein D.","J Infect Dis. 2011 Aug 1;204(3):419-25. doi: 10.1093/infdis/jir264.","Scott J","J Infect Dis","2011","2011/07/12","PMC3132139","","10.1093/infdis/jir264"
